Notably, GOT2 is essential for maintaining growth and inhibiting senescence in pancreatic cancer, but has little effect on proliferation and senescence in untransformed human pancreatic ductal cells, which may be related to the greater dependence of normal cells on glutamate dehydrogenase 1 (GLUD1).12 Here, GOT2 is linked to pancreatic neoplasm.